Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Smart Nanoparticles Designed to Identify, Target, and Kill Cancer Cells

By LabMedica International staff writers
Posted on 07 Apr 2010
Nanoparticles have been designed that can identify, target, and destroy specific cancer cells while leaving healthy cells alone.

Led by Dr. More...
Carl Batt, a professor of food science at Cornell University (Ithaca, NY, USA), the researchers synthesized nanoparticles--shaped similar to a dumbbell --made of gold sandwiched between two pieces of iron oxide. They then attached antibodies, which target a molecule found only in colorectal cancer cells, to the particles. Once bound, the nanoparticles are engulfed by the cancer cells.

To kill the cells, the researchers used a near-infrared laser, which is a wavelength that does not harm normal tissue at the levels utilized, but the radiation is absorbed by the gold in the nanoparticles. This causes the cancer cells to heat up and die. "This is a so-called ‘smart' therapy,” Dr. Batt said. "To be a smart therapy, it should be targeted, and it should have some ability to be activated only when it's there and then kills just the cancer cells.”

The goal, according to lead author and biomedical graduate student Dickson Kirui, is to improve the technology and make it suitable for testing in a human clinical trial. The researchers are now working on a similar experiment targeting prostate cancer cells. "If, down the line, you could clinically just target the cancer cells, you could then spare the health surrounding cells from being harmed--that is the critical thing,” Mr. Kirui said.

Gold has potential as a material key to combating cancer in future smart therapies. It is biocompatible, inert, and comparatively easy to modify chemically. By changing the size and shape of the gold particle, the investigators can tune them to respond to different wavelengths of energy.

Once taken up by the researchers' gold particles, the cancer cells are destroyed by heat--just a few degrees above normal body temperature--while the surrounding tissue is left unharmed. Such a low-power laser does not have any effect on surrounding cells because that specific wavelength does not heat up cells if they are not loaded up with nanoparticles, the researchers explained.

Using iron oxide, which is essentially rust, as the other parts of the particles might one day allow scientists to also track the progress of cancer treatments using magnetic resonance imaging, Mr. Kirui noted, by taking advantage of the particles' magnetic properties.

The research was published in the February 15, 2010, online edition of the journal Nanotechnology.

Related Links:

Cornell University




Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.